Merit Medical Systems (MMSI) Receiving Somewhat Positive News Coverage, Study Finds

Headlines about Merit Medical Systems (NASDAQ:MMSI) have been trending somewhat positive on Friday, according to Accern Sentiment. The research group identifies negative and positive news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Merit Medical Systems earned a media sentiment score of 0.20 on Accern’s scale. Accern also gave headlines about the medical instruments supplier an impact score of 45.7851017222315 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

Several research analysts recently weighed in on MMSI shares. Citigroup cut Merit Medical Systems from a “strong-buy” rating to an “outperform” rating and set a $44.00 target price for the company. in a research note on Monday, August 28th. They noted that the move was a valuation call. Raymond James Financial reaffirmed an “outperform” rating and set a $44.00 target price on shares of Merit Medical Systems in a research note on Monday, August 28th. UBS cut Merit Medical Systems from a “strong-buy” rating to an “outperform” rating in a research note on Monday, August 28th. Zacks Investment Research raised Merit Medical Systems from a “hold” rating to a “buy” rating and set a $43.00 target price for the company in a research note on Saturday, October 28th. Finally, Canaccord Genuity raised their target price on Merit Medical Systems from $45.00 to $47.50 and gave the company a “buy” rating in a research note on Thursday, October 26th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and eleven have given a buy rating to the company. The company has a consensus rating of “Buy” and a consensus price target of $43.77.

Merit Medical Systems (NASDAQ MMSI) opened at $43.40 on Friday. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.78 and a quick ratio of 1.43. Merit Medical Systems has a 1 year low of $24.23 and a 1 year high of $45.50. The firm has a market capitalization of $2,180.00, a price-to-earnings ratio of 34.37, a P/E/G ratio of 2.96 and a beta of 1.23.

Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings results on Wednesday, October 25th. The medical instruments supplier reported $0.32 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.30 by $0.02. Merit Medical Systems had a return on equity of 9.86% and a net margin of 4.06%. The business had revenue of $179.30 million during the quarter, compared to analyst estimates of $181.28 million. During the same quarter last year, the company posted $0.26 EPS. Merit Medical Systems’s revenue for the quarter was up 14.2% on a year-over-year basis. research analysts expect that Merit Medical Systems will post 1.27 earnings per share for the current fiscal year.

In related news, Director Kent W. Stanger sold 2,918 shares of the stock in a transaction on Thursday, November 30th. The stock was sold at an average price of $44.55, for a total value of $129,996.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 5.00% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This news story was reported by Sports Perspectives and is the property of of Sports Perspectives. If you are accessing this news story on another domain, it was stolen and republished in violation of international copyright and trademark laws. The original version of this news story can be read at https://sportsperspectives.com/2017/12/15/merit-medical-systems-mmsi-receiving-somewhat-positive-news-coverage-study-finds.html.

About Merit Medical Systems

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Insider Buying and Selling by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply